The hugely expensive multi-step acquisition of Alcon from Nestlé and minority shareholders (#msg-45072999) must rank as one of the worst M&A transactions in the drug/biotech industry during the past decade.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”